ALNY Jan 2025 150.000 call
- Yahoo Finance Video
Tech sector growth, EU considers fining Apple: Morning Brief
It's a new trading week — and the last of June — so start Monday off right with Brad Smith and Madison Mills on Yahoo Finance's The Morning Brief as they guide investors through the top stock stories and the market's opening bell. MacroPolicy Perspectives Founder and President Julia Coronado joins the show to discuss the forecast on any Federal Reserve interest rate cuts ahead of Friday's PCE (Personal Consumption Expenditures) index data. Later, Commonwealth Financial Network CIO Brad McMillan talks about the tech sector (XLK) trends becoming apparent in the broader market (^DJI, ^IXIC, ^GSPC). European Commission regulators are suing Apple (AAPL) after finding its App Store payment practices in violation of the EU's Digital Markets Act. Several other top trending tickers on Yahoo Finance this morning, include bitcoin (BTC-USD), Target (TGT) and Shopify (SHOP), Eli Lilly (LLY), and Boeing (BA). This post was written by Luke Carberry Mogan.
- Yahoo Finance Video
Alnylam stock skyrockets on positive heart drug results
Shares of Alnylam Pharmaceuticals (ALNY) are jumping Monday morning after the company released positive results for its heart therapy medication, which was shown to reduce the risk of death from hospitalization by 28%. Yahoo Finance Health Reporter Anjalee Khemlani joins Morning Brief to break down the latest developments from Alnylam and what it means for the pharmaceutical company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Nicholas Jacobino
- Investor's Business Daily
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
Alnylam stock catapulted Monday after its experimental heart-disease treatment topped expectations in a highly anticipated study.
